Specific bacterial metabolites, particularly short-chain fatty acids like butyrate, bind to receptors on L-cells (specifically GPR41 and GPR43) and stimulate GLP-1 release
GLP-1 drugs are muting flavours and making food taste off Sweetness hits differently as brain responses shift Brands are boosting umami and texture to bring flavour back Smaller, protein-packed meals are leading the charge Growing scientific research and anecdotal evidence suggest that GLP-1 drugs may change how people experience taste
Patient Testimonials See what the Klinic community is saying Deborah Allen How Klinic's Metabolic Health Program Works Get matched with a licensed provider Fill our a short form and we will verify your insurance and match you with the right provider Complete an online visit Answer questions about your weight loss goals, medical history, and current medications and our provider will create a personalized treatment plan for you Medication shipped to you and Prior Authorization Support In case medication is prescribed, we will handle the prior authorization process with your insurer and you will get medication delivered to your door, with ongoing provider support
Based on your consent, we may share information about your website interactions (e.g., pages viewed, products interacted with) with advertising platforms such as Google and Meta for the purpose of creating advertising audiences and personalising ads across Vision Healthcare brands
With the introduction of dual GLP-1/GIP-RA, ongoing studies could provide novel insights and new evidence on this topic
.png)
